You Only Find what you Look for: The Importance of High Creatinine Clearance in the Critically Ill

Roberts J.A. , Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 2006; 45: 755–773.

Fuster-Lluch O. , Geronimo-Pardo M. , Peyro-Garcia R. , Lizan-Garcia M. Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care 2008; 36: 674–680.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 2002; 39(Suppl 1): S46–75.

Sunder-Plassmann G. , Horl W.H. A critical appraisal for definition of hyperfiltration. Am J Kidney Dis 2004; 43: 396.

Dulhunty J.M. , Lipman J. , Finfer S. Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand Intensive Care Unit Study. Intensive Care Med 2008; 34: 1654–1661.

Ishikawa M. , Nishioka M. , Hanaki N. , Kikutsuji T. , Miyauchi T. , Kashiwagi Y. Postoperative metabolic and circulatory responses in patients that express SIRS after major digestive surgery. Hepatogastroenterology 2006; 53: 228–233.

Di Giantomasso D. , May C.N. , Bellomo R. Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med 2003; 29: 1774–1781.

Bellomo R. , Wan L. , May C. Vasoactive drugs and acute kidney injury. Crit Care Med 2008; 36(4 Suppl): S179–186.

Gombos E.A. , Flulet W.H. , Bopp P. , Goldring W. , Baldwin D.S. , Chasis H. Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects. J Clin Invest 1962; 41: 203–217.

Mills L.C. , Moyer J.H. , Handley C.A. Effects of various sympathicomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol 1960; 198: 1279–1283.

Richer M. , Robert S. , Lebel M. Renal hemodynamics during norepinephrine and low dose dopamine infusions in man. Crit Care Med 1996; 24: 1150–1156.

Di Giantomasso D. , May C.N. , Bellomo R. Norepinephrine and vital organ blood flow. Intensive Care Med 2002; 28: 1804–1809.

Bellomo R. , Kellum J.A. , Wisniewski S.R. , Pinsky M.R. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159: 1186–1192.

Hoste E.A. , Damen J. , Vanholder R.C. , Lameire N.H. , Delanghe J.R. , Van den Hauwe K. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005; 20: 747–753.

Levey A.S. , Bosch J.P. , Lewis J.B. , Greene T. , Rogers N. , Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.

Poggio E.D. , Nef P.C. , Wang X. , Greene T. , Van Lente F. , Dennis V.W. Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalised patients. Am J Kidney Dis 2005; 46: 242–252.

Kim K.E. , Onesti G. , Ramirez O. , Brest A.N. , Swartz C. Creatinine clearance in renal disease. A reappraisal. Br Med J 1969; 4: 11–19.

Wells M. , Lipman J. Measurements of glomerular filtration in the intensive care unit are only a rough guide to renal function. S Afr J Surg 1997; 35: 20–23.

Wells M. , Lipman J. Pitfalls in the prediction of renal function in the intensive care unit. A review. S Afr J Surg 1997; 35: 16–19.

Pong S. , Seto W. , Abdolell M. , Trope A. , Wong K. , Herridge J. 12-hour versus 24-hour creatinine clearance in critically ill pediatric patients. Pediatr Res 2005; 58: 83–88.

Herrera-Gutiérrez M.E. , Seller-Pérez G. , Banderas-Bravo E. , Muñoz-Bono J. , Lebrón-Gallardo M. , Fernandez-Ortega J.F. Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a single-center study. Intensive Care Med 2007; 33: 1900–1906.

Sladen R.N. , Endo E. , Harrison T. Two-hour versus 22-hour creatinine clearance in critically ill patients. Anesthesiology. 1987; 67: 1013–1016.

Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1–10.

Turnidge J.D. The pharmacodynamics of beta-lactams. Clin Infect Dis 1998; 27: 10–22.

Lipman J. , Wallis S.C. , Rickard C.M. , Fraenkel D. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing. Intensive Care Med 2001; 27: 363–370.

Lipman J. , Wallis S.C. , Rickard C. Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modelling indicates improved troughs with revised dosing. Antimicrob Agents Chemother 1999; 43: 2559–2561.

Lipman J. , Wallis S.C. , Boots R.J. Cefepime versus cefpirome: the importance of creatinine clearance. Anesth Analg 2003; 97: 1149–1154.

del Mar Fernández de Gatta Garcia M. , Revilla N. , Calvo M.V. , Domínguez-Gil A. , Sánchez Navarro A. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med 2007; 33: 279–285.

Conil J.M. , Georges B. , Lavit M. , Seguin T. , Tack I. , Samii K. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance. Int J Clin Pharmacol Ther 2007; 45: 529–538.

Panomvana D. , Kiatjaroensin S.A. , Phiboonbanakit D. Correlation of the pharmacokinetic parameters of amikacin and ceftazidime. Clin Pharmacokinet 2007; 46: 859–866.

Ikawa K. , Morikawa N. , Ikeda K. , Ohge H. , Sueda T. , Suyama H. Pharmacokinetic-pharmacodynamic target attainment analysis of biapenem in adult patients: a dosing strategy. Chemotherapy 2008; 54: 386–394.

Conil J.M. , Georges B. , Mimoz O. , Dieye E. , Ruiz S. , Cougot P. Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients. Intensive Care Med 2006; 32: 2063–2066.

Roberts J.A. , Kruger P. , Paterson D.L. , Lipman J. Antibiotic resistance – What's dosing got to do with it? Crit Care Med 2008; 36: 2433–2440.